These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 37194022)
21. [THE ROLE OF SEMAPHORIN 7A IN SYSTEMIC SCLEROSIS]. Rimar D; Slobodin G; Rosner I; Rozenbaum M; Kaly L; Boulman N; Jiries N; Awisat A; Vadasz Z Harefuah; 2017 Jul; 156(7):418-421. PubMed ID: 28786275 [TBL] [Abstract][Full Text] [Related]
22. Pirfenidone and nintedanib attenuate pulmonary fibrosis in mice by inhibiting the expression of JAK2. Yang Y; Wang X; Zhang J J Thorac Dis; 2024 Feb; 16(2):1128-1140. PubMed ID: 38505034 [TBL] [Abstract][Full Text] [Related]
24. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis. Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756 [TBL] [Abstract][Full Text] [Related]
26. Blockade of IL-11 Trans-Signaling or JAK2/STAT3 Signaling Ameliorates the Profibrotic Effect of IL-11. Ye W; Wang Q; Zhao L; Wang C; Zhang D; Zhou M; Chen F; Wang W; Zhu Z; Guo W; Liu Y; Zou H; Xue Y Immunol Invest; 2023 Nov; 52(6):703-716. PubMed ID: 37401665 [TBL] [Abstract][Full Text] [Related]
27. [Effects of Wenyang Huazhuo Tongluo Recipe Containing Serum on Transforming Growth Factor β1/ Smad Signaling Pathway of Skin Fibroblasts in Systemic Sclerosis]. Bian H; Lv Q; Huang XZ; Hu JL; Yang L; Mao BY Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Sep; 35(9):1054-9. PubMed ID: 26591358 [TBL] [Abstract][Full Text] [Related]
28. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways. Lv Q; Wang J; Xu C; Huang X; Ruan Z; Dai Y Mol Med; 2020 May; 26(1):49. PubMed ID: 32448163 [TBL] [Abstract][Full Text] [Related]
29. Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis. Venkatesan N; Tsuchiya K; Kolb M; Farkas L; Bourhim M; Ouzzine M; Ludwig MS Am J Respir Cell Mol Biol; 2014 Mar; 50(3):583-94. PubMed ID: 24127863 [TBL] [Abstract][Full Text] [Related]
30. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway. Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522 [TBL] [Abstract][Full Text] [Related]
31. Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease. Lee R; Reese C; Bonner M; Tourkina E; Hajdu Z; Riemer EC; Silver RM; Visconti RP; Hoffman S Am J Physiol Lung Cell Mol Physiol; 2014 Apr; 306(8):L736-48. PubMed ID: 24583879 [TBL] [Abstract][Full Text] [Related]
32. Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway. Chen S; Wei Y; Li S; Miao Y; Gu J; Cui Y; Liu Z; Liang J; Wei L; Li X; Zhou H; Yang C Int Immunopharmacol; 2022 Dec; 113(Pt A):109316. PubMed ID: 36252483 [TBL] [Abstract][Full Text] [Related]
33. Dual αvβ3 and αvβ5 blockade attenuates fibrotic and vascular alterations in a murine model of systemic sclerosis. Bagnato GL; Irrera N; Pizzino G; Santoro D; Roberts WN; Bagnato G; Pallio G; Vaccaro M; Squadrito F; Saitta A; Altavilla D; Bitto A Clin Sci (Lond); 2018 Jan; 132(2):231-242. PubMed ID: 29237724 [TBL] [Abstract][Full Text] [Related]
34. Simiao pill attenuates collagen-induced arthritis and bleomycin-induced pulmonary fibrosis in mice by suppressing the JAK2/STAT3 and TGF-β/Smad2/3 signalling pathway. Ba X; Wang H; Huang Y; Yan J; Han L; Lin W; Shen P; Huang Y; Yang S; Qin K; Tu S; Chen Z J Ethnopharmacol; 2023 Jun; 309():116274. PubMed ID: 36841380 [TBL] [Abstract][Full Text] [Related]
35. Integrative analysis of lung molecular signatures reveals key drivers of systemic sclerosis-associated interstitial lung disease. Jung SM; Park KS; Kim KJ Ann Rheum Dis; 2022 Jan; 81(1):108-116. PubMed ID: 34380701 [TBL] [Abstract][Full Text] [Related]
36. Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma-Associated Lung Fibrosis. Bogatkevich GS; Atanelishvili I; Bogatkevich AM; Silver RM Arthritis Rheumatol; 2023 Mar; 75(3):438-448. PubMed ID: 36103378 [TBL] [Abstract][Full Text] [Related]
37. The involvement of leucine-rich α-2 glycoprotein in the progression of skin and lung fibrosis in bleomycin-induced systemic sclerosis model. Nakajima H; Nakajima K; Serada S; Fujimoto M; Naka T; Sano S Mod Rheumatol; 2021 Nov; 31(6):1120-1128. PubMed ID: 33535851 [TBL] [Abstract][Full Text] [Related]
38. Scorpion Venom Polypeptide Inhibits Pulmonary Epithelial-Mesenchymal Transition in Systemic Sclerosis-Interstitial Lung Disease Model Mice by Intervening TGF- Zhang Y; Xu L; Chen Q; Guan T; Lin N; Xu D; Lu L; Dai Q; Song X Evid Based Complement Alternat Med; 2022; 2022():6557486. PubMed ID: 35463079 [TBL] [Abstract][Full Text] [Related]
40. Amelioration of bleomycin-induced pulmonary fibrosis via TGF-β-induced Smad and non-Smad signaling pathways in galectin-9-deficient mice and fibroblast cells. Hsu YA; Chang CY; Lan JL; Li JP; Lin HJ; Chen CS; Wan L; Liu FT J Biomed Sci; 2020 Jan; 27(1):24. PubMed ID: 31937306 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]